Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double‐blind, placebo‐controlled study

Chinese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong

Journal of Diabetes ◽

10.1111/1753-0407.12425 ◽

2016 ◽

Vol 9 (4) ◽

pp. 386-395 ◽

Cited By ~ 10

Author(s):

Changyu Pan ◽

Ping Han ◽

Qiuhe Ji ◽

Chengjiang Li ◽

Juming Lu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Hong Kong ◽

Mainland China ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14231 ◽

2020 ◽

Author(s):

Wenying Yang ◽

Xiangjin Xu ◽

Tao Lei ◽

Jianhua Ma ◽

Ling Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study

Current Medical Research and Opinion ◽

10.1185/03007995.2014.912983 ◽

2014 ◽

Vol 30 (7) ◽

pp. 1245-1255 ◽

Cited By ~ 64

Author(s):

Yutaka Seino ◽

Takashi Sasaki ◽

Atsushi Fukatsu ◽

Michito Ubukata ◽

Soichi Sakai ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Phase III, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

Journal of Diabetes Investigation ◽

10.1111/jdi.13389 ◽

2020 ◽

Author(s):

Linong Ji ◽

Jianhua Ma ◽

Weiping Lu ◽

Jingdong Liu ◽

Jiao’e Zeng ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Chinese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Diet And Exercise

Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

Diabetologia ◽

10.1007/s00125-021-05460-0 ◽

2021 ◽

Author(s):

Linong Ji ◽

Ying Du ◽

Min Xu ◽

Xiangjun Zhou ◽

Zhaohui Mo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Ii ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Treatment Naïve

Transglucosidase Improves the Bowel Movements in Type 2 Diabetes Mellitus Patients: A Randomized Double-Blind, Placebo-Controlled Study

Gastroenterology ◽

10.1016/s0016-5085(17)33434-0 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1012-S1013

Author(s):

Makoto Sasaki ◽

Akihiro Shimozato ◽

Naotaka Ogasawara ◽

Yasushi Funaki ◽

Masahide Ebi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Bowel Movements

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Cardiovascular Diabetology ◽

10.1186/s12933-016-0407-4 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 35

Author(s):

Nobuya Inagaki ◽

Shin-ichi Harashima ◽

Nobuko Maruyama ◽

Yutaka Kawaguchi ◽

Maki Goda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study

Clinical Nutrition ◽

10.1016/j.clnu.2015.11.011 ◽

2017 ◽

Vol 36 (1) ◽

pp. 85-92 ◽

Cited By ~ 95

Author(s):

Livia Bordalo Tonucci ◽

Karina Maria Olbrich dos Santos ◽

Leandro Licursi de Oliveira ◽

Sonia Machado Rocha Ribeiro ◽

Hercia Stampini Duarte Martino

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Application ◽

Controlled Study ◽

Double Blind ◽

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients with Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism ◽

10.31031/gjem.2018.02.000543 ◽

2018 ◽

Vol 2 (4) ◽

Author(s):

Davis Townsend

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽